Related Experiment Video
Updated: Aug 19, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
[Oxidative stress in preeclampsia]
Insights
Preeclampsia, a leading cause of maternal mortality, is linked to decreased plasma antioxidant activity. Increased lipid peroxidation may damage blood vessels, causing preeclampsia symptoms.
Area of Science:
- Obstetrics and Gynecology
- Biochemistry
- Pathophysiology
Context:
- Preeclampsia is a significant contributor to maternal and perinatal mortality worldwide.
- Reduced antioxidant capacity in plasma is observed in women diagnosed with preeclampsia.
- Elevated levels of lipid peroxidation products are implicated in the pathogenesis of preeclampsia.
Purpose:
- To investigate the role of decreased antioxidant activity and increased lipid peroxidation in the development of preeclampsia.
- To explore the relationship between oxidative stress markers and clinical manifestations of preeclampsia.
Summary:
- Women with preeclampsia exhibit diminished plasma antioxidant activity.
- Increased lipid peroxidation products contribute to peroxidative damage of the vascular endothelium.
- This endothelial damage is a potential mechanism leading to the clinical symptoms observed in preeclampsia.
Impact:
- Understanding these mechanisms can inform the development of novel diagnostic markers for preeclampsia.
- This research may pave the way for targeted therapeutic interventions aimed at mitigating oxidative stress in preeclampsia.
- Highlights the importance of addressing oxidative stress in maternal healthcare to reduce mortality rates.
Abstract:
Preeclampsia is the main case of maternal and perinatal mortality. In women with preeclampsia antioxidant activity of plasma is decreased. Increased levels of of lipid peroxidation products may case peroxidative damage of vascular endotelium and result in clinical symptoms of preeclampsia.
Related Concept Videos
Peroxisomes
Bioactivation and Tissue Toxicity
Diabetic Retinopathy

